Zometa

Active Ingredient(s): Zoledronic Acid
FDA Approved: * August 20, 2001
Pharm Company: * NOVARTIS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Zometa Overview

Zoledronic acid, also known as zoledronate, is a medication used to treat a number of bone diseases.[3] These include osteoporosis, high blood calcium due to cancer, bone breakdown due to cancer, and Paget’s disease of bone.[3] It is given by injection into a vein.[3] Common side effects include fever, joint pain, high blood pressure, diarrhea, and feeling tired.[3] Serious side effects may include kidney problems, low bloo...

Read more Zometa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Zoledronic_acid

Recent Zometa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Zoledronic Acid

Injection: 0.05mg/ml, 0.8mg, 4mg, 4mg/100ml, 4mg/100ml(0.04mg/ml), 4mg/5ml, 4mg/5ml(0.8mg/ml), 4mg/vial, 4mmg, 5mg/100ml
Solution: 4mg/100ml (0.04mg/ml)

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zometa: (2 results)

Sorted by National Drug Code

0078-0387 Zometa 4 mg/5ml Intravenous Injection, Solution, Concentrate by Novartis Pharmaceuticals Corporation
0078-0590 Zometa 4 mg/100ml Intravenous Injection, Solution, Concentrate by Novartis Pharmaceuticals Corporation

Zometa

Zometa Overview

Recent Zometa Forums:

Possible Dosages for this and Related Drugs:

NDC Database Records for Zometa: (2 results)

Other drugs which contain Zoledronic Acid or a similar ingredient: (3 results)

Related Zometa Topics: